Skip to main content

Table 1 Regulatory likelihood of the investigated SNPs according to the RegulomeDB database

From: Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment

a.

Gene

Functional consequence

SNP

Position

Regulome DB score

eQTL (Monocytes)

Histone modification

Chromatin state

Blood cells

Protein binding

K562

 

SLC22A4

Intron 3

rs156322

A/G

chr5:131653924

1f

SLC22A4

SLC22A5

Quiescent/Low

T, B and NK cells from PB

Strong transcription

Primary neutrophils, monocytes, MNC from PB

Weak transcription

Primary HSC

Genic enhancers

K562

NA

 

SLC22A4

Intron 3

rs272842

C/T

chr5:131656516

1f

SLC22A4

SLC22A5

Quiescent/Low

T, B and NK cells from PB

Strong transcription

Primary neutrophils and monocytes from PB

Weak transcription

Primary HSC, MNC from PB, K562

NA

 

SLC22A4

Intron 5

rs272889

C/T

chr5:131665377

1f

SLC22A4

SLC22A5

Quiescent/Low

Primary T, B and NK cells from PB

Strong transcription

MNC from PB

Weak transcription

T-helper naïve from PB, K562, primary HSC

NA

 

SLC22A4

Intron 8

rs272872

C/T

chr5:131675863

1f

SLC22A4

SLC22A5

Quiescent/Low

primary T, B and NK cells from PB

Strong transcription

MNC from PB

Weak transcription

T-helper naïve from PB, K562, primary HSC

NA

 

SLC22A5

Intron 1

rs2631363

C/T

chr5:131707094

2b

NA

NA

RBBP5, POLR3A

 

SLC22A5

Intron 1

rs2631362

C/T

chr5:131707292

1f

SLC22A4

SLC22A5

Enhancers

MNC and T cells from PB

Flanking active TSS

K562

Weak transcription

MNC from PB, primary HSC

RBBP5

 

SLC22A5

Intron 1

rs274570

A/G

chr5:131713225

1f

SLC22A4

SLC22A5

Quiescent/Low

Primary T cells from PB

Weak transcription

primary HSC, MNC from PB, K562

NA

 

SLC22A5

Intron 2

rs274567

A/G

chr5:131714408

1f

SLC22A4

SLC22A5

Quiescent/Low

T regulatory and helper cells, primary neutrophils from PB

Strong transcription

K562, primary T cells from PB, primary HSC G-CSF mobilized female and male

Weak transcription

primary HSC, primary T, B and NK cells from PB

NA

 

SLC22A5

Intron 2

rs183898

C/G

chr5:131716901

3a

NA

Quiescent/Low

Primary neutrophils from PB, T regulatory and helper cells from PB

Weak Transcription

B cells, MNC form PB, K562, primary HSC short term culture

NA

 

SLC22A5

Intron 3

rs274559

C/T

chr5:131720069

1f

SLC22A4

SLC22A5

Quiescent/Low

primary neutrophils from PB, T regulatory and helper cells from PB

Strong Transcription

K562

Weak Transcription

primary HSC, primary NK cells from PB, T and B cells from PB, MNC from PB

NA

 

b.

Gene

Functional consequence

SNP

Position

Regulome DB score

Histone modification

Chromatin state

Blood cells

Protein binding

K562

Motif

(cell type)

Position-Weight Matrix for TF binding

Ref. sequence of SNP

SLC22A4

Promoter

rs460089

C/G

chr5:131629771

2a

NA

POLR2A, PHF8, HMGN3, UBTF, CTCF, ATF3, USF1, MAX, MYC, CBX3, UBTF, ZBTB7A, CCNT2, E2F6, IRF1, BCLAF1, ETS1

MYC:MAX

(K562)

SLC22A4

Intron 3

rs270606

C/T

chr5:131650866

3a

NA

HDAC8

STAT5A

(NA)

Downstream from SLC22A4

(LOC553103 intron 3)

rs272868

C/G

chr5:131680750

3a

Quiescent/Low

Primary T and B cells from PB

Strong transcription MNC from PB

Weak transcription

T-helper naïve from PB, K562, primary HSC

STAT1, STAT2, CEBPB

MEOX2

(NA)

SLC22A5

NC transcript variant, UTR variant 5 prime

rs13180043

C/T

chr5:131705586

2b

NA

POLR2A, PHF8, TAF1, ETS1, IRF1, MYC, UBTF, RBBP5, SAP30, MAX, E2F6, NRF1, HMGN3, KDM5B, E2F1

HIC1

(K562)

SLC22A5

NC transcript variant, UTR variant 5 primes

rs13180295

G/A

chr5:131705587

2b

NA

POLR2A, PHF8, TAF1, ETS1, IRF1, MYC, UBTF, RBBP5, SAP30, MAX, E2F6, NRF1, HMGN3, KDM5B, E2F1

HIC1

(K562)

  1. The table is divided into two sections for clarity. a. Summary of the eQTL, chromatin state in blood cells and protein binding in K562. b. Summary of protein binding in K562, motifs, Position-Weight Matrix (PWM) for transcription factor binding and chromatin state in blood cells. Legend: 1f–likely to affect binding and linked to expression of a gene target (eQTL + TF binding/DNase peak); 2a–likely to affect binding (TF binding + matched TF motif + matched DNase Footprint + DNase peak); 2b–likely to affect binding (TF binding + any motif + DNase Footprint + DNase peak); 3a–less likely to affect binding (TF binding + any motif + DNase peak)